Filing Details

Accession Number:
0001140361-11-012309
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-25 12:00:00
Reporting Period:
2011-02-23
Filing Date:
2011-02-25
Accepted Time:
2011-02-25 17:02:53
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880643 Genta Inc De GNTAD Biological Products, (No Disgnostic Substances) (2836) 330326866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1100843 Jr P Raymond Warrell C/O Genta Incorporated
200 Connell Drive
Berkeley Heights NJ 07922
Chairman & Chief Exec Officer Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2011-02-23 130,000 $0.21 20,814,588 No 4 S Direct
Common Stock Disposition 2011-02-24 140,000 $0.17 20,674,588 No 4 S Direct
Common Stock Disposition 2011-02-25 160,000 $0.15 20,514,588 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 152,695 Indirect By spouse
Footnotes
  1. Includes 300,000 shares of common stock held jointly with Dr. Warrell's spouse, Dr. Itri, 119,632 shares of common stock potentially issuable upon the vesting of currently outstanding restricted stock units held by Dr. Warrell, 10,590,399 shares of common stock issuable upon the conversion of Senior Convertible Promissory Notes due September 9, 2011, as amended, (the Notes), held in joint account with Dr. Itri, 60,650 shares of common stock issuable upon the conversion of Notes held by Dr. Warrell's IRA, 8,612,823 shares of common stock issuable upon the exercise of March 2010 Warrants held in joint account with Dr. Itri, 1,125,019 shares of common stock issuable upon the exercise of December 2010 Warrants held in joint account with Dr. Itri and 6,065 shares of common stock issuable upon the exercise of December 2010 Warrants held by Dr. Warrell's IRA.
  2. Includes 52,622 shares of common stock potentially issuable upon the vesting of currently outstanding restricted stock units held by Dr. Itri, 90,975 shares of common stock issuable upon the conversion of Notes held by Dr. Itri's IRA and 9,098 shares of common stock issuable upon the exercise of December 2010 Warrants held by Dr. Itri's IRA.